← Leaderboards
Christopher John Tompkins
Kromatid, Inc.
$4,215,186
Attributed
$4,215,186
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2018–22$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,215,186 · 3
By mechanism
R44$4,215,186 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,487,925
- Lynn Briscoe · Leidos Biomedical Research, Inc.$121,890,535
- Yunda Huang · Fred Hutchinson Cancer Center$58,111,165
- Leonard Freedmand · Leidos Biomedical Research, Inc.$57,401,321
- John Damon Chodera · Sloan-Kettering Inst Can Research$53,758,943
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$33,980,897
Research focus
ScreeningSamplingPaintMedicalResearch And DevelopmentResolutionFundingGenomic HybridizationsDensityMalignant NeoplasmsPharmacologic SubstanceBaseBioinformaticsChromatidsDetectionDna RepairBiomedical ResearchGenesComplexCommercial ApplicationCrispr/Cas TechnologyGovernmentCellsStructure
Grant awards (6)
A comprehensive quality control testing strategy for engineered cells$350,457
R44 · FY2022 · TR · contact PI
A comprehensive quality control testing strategy for engineered cells$1,284,984
R44 · FY2021 · TR · contact PI
Automated, high-throughput identification of genetic structural variants for gene editing and undiagnosed genetic diseases screening$584,436
R44 · FY2021 · HG · contact PI
Automated, high-throughput identification of genetic structural variants for gene editing and undiagnosed genetic diseases screening$1,088,162
R44 · FY2020 · HG · contact PI
Rapid, cost-effective whole genome screening tools for cryptic inversions and translocations$700,550
R44 · FY2019 · HG · contact PI
Rapid, cost-effective whole genome screening tools for cryptic inversions and translocations$206,597
R44 · FY2018 · HG · contact PI